FrancophonIA/ELRC3.0 huggingface dataset:
English: Each Exelon 1.5 mg capsule contains 1.5 mg of rivastigmine.
Estonian: Üks Exelon 1,5 mg kapsel sisaldab 1,5 mg rivastigmiini.
English: Gently pull at one edge of the patch to remove it slowly from the skin.
Estonian: Kuidas Exelon transdermaalseid plaastreid eemaldada Tõmmake ettevaatlikult lahti plaastri üks serv ja eemaldage see aeglaselt naha küljest.
English: Where to apply your Exelon transdermal patch
Estonian: Kuhu Exelon transdermaalsed plaastrid kinnitada
English: • Paediatric population: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Estonian: • Lapsed: Puudub Exelon'i asjakohane kasutus lastel Alzheimeri tõve ravis.
English: Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules
Estonian: Exelon 1,5 mg kõvakapslid Exelon 3,0 mg kõvakapslid Exelon 4,5 mg kõvakapslid Exelon 6,0 mg kõvakapslid
English: 42 transdermal patches.
Estonian: 42 transdermaalset plaastrit, multipakendi komponent.
English: Each Exelon 4.5 mg capsule contains 4.5 mg of rivastigmine.
Estonian: Üks Exelon 4,5 mg kapsel sisaldab 4,5 mg rivastigmiini.
English: How to use Exelon
Estonian: Kuidas Exelon'i kasutada
English: The outside of the backing layer is beige and labelled with “Exelon”, “13.3 mg/24 h” and “CNFU”.
Estonian: Plaastri tagakülg on beež ja märgistusega “Exelon”, “13.3 mg/24 h” ja “CNFU”.
English: Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules rivastigmine
Estonian: Exelon 1,5 mg kõvakapslid Exelon 3,0 mg kõvakapslid Exelon 4,5 mg kõvakapslid Exelon 6,0 mg kõvakapslid rivastigmiin (Rivastigminum)
English: No specific interaction studies have been performed with Exelon transdermal patches.
Estonian: Exelon transdermaalsete plaastritega ei ole spetsiifilisi koostoimeid uuritud.
English: Your doctor will tell you what dose of Exelon to take.
Estonian: Arst ütleb, milline Exelon'i annus manustada.
English: The incidence of application site skin reactions leading to discontinuation was ≤2.3% in patients treated with Exelon transdermal patches.
Estonian: Exelon transdermaalsete plaastritega ravi saanud patsientidel oli katkestamise määr manustamiskoha nahareaktsioonide tõttu ≤2,3%.
English: Exelon 13.3 mg/24 h transdermal patches: Each patch releasing 13.3 mg of rivastigmine per 24 hours is 15 cm and contains 27 mg of rivastigmine.
Estonian: Exelon 13,3 mg/24 h transdermaalsed plaastrid: Üks plaaster vabastab 24 tunni jooksul 13,3 mg rivastigmiini ning 15 cm plaaster sisaldab 27 mg rivastigmiini.
English: • The signs of Parkinson's disease get worse or getting similar signs - such as stiff muscles, difficulty in carrying out movements and muscle weakness
Estonian: • Parkinsoni tõvele sarnaste sümptomite teke või süvenemine - lihasjäikus, liikumisraskus ja lihasnõrkus
English: How to take Exelon
Estonian: Kuidas Exelon'i võtta
English: - Exelon 9.5 mg/24 h transdermal patches: Each patch releasing 9.5 mg of rivastigmine per 24 hours is 10 cm and contains 18 mg of rivastigmine.
Estonian: Exelon 9,5 mg/24 h transdermaalsed plaastrid: Üks plaaster vabastab 24 tunni jooksul 9,5 mg rivastigmiini ning 10 cm plaaster sisaldab 18 mg rivastigmiini.
English: Each Exelon 3.0 mg capsule contains 3.0 mg of rivastigmine.
Estonian: Üks Exelon 3,0 mg kapsel sisaldab 3,0 mg rivastigmiini.
English: The outside of the backing layer is beige and labelled with “Exelon”, “9.5 mg/24 h” and “BHDI”.
Estonian: Plaastri tagakülg on beež ja märgistusega “Exelon”, “9.5 mg/24 h” ja “BHDI”.
English: What Exelon contains - The active substance is rivastigmine hydrogen tartrate.
Estonian: Mida Exelon sisaldab - Toimeaine on rivastigmiinvesiniktartraat.
English: One of the excipients in Exelon oral solution is sodium benzoate.
Estonian: Exelon suukaudse lahuse üheks abiaineks on naatriumbensoaat.
English: Hepatitis Skin and subcutaneous tissue disorders Common
Estonian: Naha ja nahaaluskoe kahjustused Sage
English: colloidal anhydrous silica, gelatin, yellow iron oxide (E172), red iron oxide (E172), titanium dioxide (E171) and shellac.
Estonian: - Teised koostisosad on hüpromelloos, magneesiumstearaat, mikrokristalne tselluloos, kolloidne ränidioksiid, želatiin, kollane raudoksiid (E172), punane raudoksiid (E172), titaandioksiid
English: Transdermal patches Rivastigmine in vivo release rates per 24 h
Estonian: 24 tunni jooksul in vivo vabanev rivastigmiini annus
English: Application site skin reactions (usually mild to moderate application site erythema), are the most frequent adverse reactions observed with the use of Exelon transdermal patch.
Estonian: Exelon'i transdermaalse plaastrite kasutamisel kõige sagedamini esinenud kõrvaltoimeted on nahareaktsioonid manustamiskohal (tavaliselt manustamiskoha kerge kuni mõõdukas punetus).
English: Exelon 4.6 mg/24 h transdermal patch Exelon 9.5 mg/24 h transdermal patch Exelon 13.3 mg/24 h transdermal patch rivastigmine
Estonian: Exelon 4,6 mg/24 h transdermaalne plaaster Exelon 9,5 mg/24 h transdermaalne plaaster Exelon 13,3 mg/24 h transdermaalne plaaster rivastigmiin (Rivastigminum)
English: Exelon 4.6 mg/24 h transdermal patch Exelon 9.5 mg/24 h transdermal patch Exelon 13.3 mg/24 h transdermal patch
Estonian: Exelon 4,6 mg/24 h transdermaalne plaaster Exelon 9,5 mg/24 h transdermaalne plaaster Exelon 13,3 mg/24 h transdermaalne plaaster
English: Exelon is used for the treatment of adult patients with mild to moderately severe Alzheimer's dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Estonian: See on süvenev ajuhäire, mis järk-järgult mõjutab mälu, intellektuaalset võimekust ja käitumist.
English: The active substance of Exelon is rivastigmine.
Estonian: Exelon'i toimeaine on rivastigmiin.
English: What Exelon is and what it is used for What you need to know before you use Exelon How to use Exelon
Estonian: Mis ravim on Exelon ja milleks seda kasutatakse Mida on vaja teada enne Exelon'i kasutamist Kuidas Exelon'i kasutada Võimalikud kõrvaltoimed Kuidas Exelon'i säilitada Pakendi sisu ja muu teave
English: This may indicate a potential for Exelon transdermal patches to induce mild erythema in patients.
Estonian: See võib viidata Exelon transdermaalsete plaastrite võimalikule kerget erüteemi põhjustavale toimele.
English: Caution when Exelon Patch is given together with beta-blockers (medicines such as atenolol used to treat hypertension, angina, and other heart conditions).
Estonian: Ettevaatust Exelon plaastri kasutamisel koos beetablokaatoritega (ravimid, nagu atenolool, millega ravitakse kõrget vererõhku, rinnaangiini ja teisi südamehaigusi).
English: Caution when Exelon is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions).
Estonian: Ettevaatust Exelon'i kasutamisel koos beetablokaatoritega (ravimid, nagu atenolool, millega ravitakse kõrget vererõhku, rinnaangiini ja teisi südamehaigusi).
English: You should not breast-feed during treatment with Exelon.
Estonian: Te ei tohi Exelon'i ravi ajal imetada.
English: Exelon 1.5 mg hard capsules rivastigmine
Estonian: Exelon 1,5 mg kõvakapslid Rivastigminum
English: The patient's weight should be monitored during therapy with Exelon transdermal patches.
Estonian: Ravi ajal Exelon transdermaalsete plaastritega tuleb jälgida patsiendi kehakaalu.
English: Exelon 4.5 mg hard capsules rivastigmine
Estonian: Exelon 4,5 mg kõvakapslid Rivastigminum
English: Exelon 4.6 mg/24 h transdermal patch rivastigmine
Estonian: Exelon 4,6 mg/24 h transdermaalne plaaster Rivastigminum
English: Exelon 2 mg/ml oral solution rivastigmine
Estonian: Exelon 2 mg/ml suukaudne lahus Rivastigminum
English: Exelon transdermal patches 9.5 mg/24 h
Estonian: Exelon transdermaalsed plaastrid 9,5 mg/24 h
English: Exelon 9.5 mg/24 h transdermal patch rivastigmine
Estonian: Exelon 9,5 mg/24 h transdermaalne plaaster Rivastigminum
English: Exelon 3.0 mg hard capsules rivastigmine
Estonian: Exelon 3,0 mg kõvakapslid Rivastigminum
English: Exelon 2 mg/ml oral solution
Estonian: Exelon 2 mg/ml suukaudne lahus
English: Exelon 1.5 mg hard capsules
Estonian: Exelon 1,5 mg kõvakapslid
English: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Estonian: Puudub Exelon'i asjakohane kasutus lastel Alzheimeri tõve ravis.
English: Exelon 4.6 mg/24 h transdermal patch
Estonian: Exelon 4,6 mg/24 h transdermaalne plaaster
English: How to store Exelon
Estonian: Kuidas Exelon'i säilitada
English: Exelon 13.3 mg/24 h transdermal patch rivastigmine
Estonian: Exelon 13,3 mg/24 h transdermaalne plaaster Rivastigminum
English: Overdose with Exelon transdermal patch resulting from misuse/dosing errors (application of multiple patches at a time) has been reported in the post-marketing setting and rarely in clinical trials.
Estonian: Turuletulekujärgselt ja harva kliinilistes uuringutes on teatatud Exelon transdermaalsete plaastrite ebaõigest kasutamisest/annustamisvigadest (mitme plaastri samaaegne kasutamine) tingitud üleannustamisest.
English: Exelon 6.0 mg hard capsules rivastigmine
Estonian: Exelon 6,0 mg kõvakapslid Rivastigminum
English: Exelon 6.0 mg hard capsules
Estonian: Exelon 6,0 mg kõvakapslid
English: Exelon 4.5 mg hard capsules
Estonian: Exelon 4,5 mg kõvakapslid
English: Exelon 13.3 mg/24 h transdermal patch
Estonian: Exelon 13,3 mg/24 h transdermaalne plaaster
English: Exelon 9.5 mg/24 h transdermal patch
Estonian: Exelon 9,5 mg/24 h transdermaalne plaaster
English: Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “EXELON 1,5 mg” on body.
Estonian: Kapsli alaosale on punaselt trükitud “EXELON 1,5 mg”.
English: Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “EXELON 6 mg” on body.
Estonian: Kapsli alaosale on punaselt trükitud “EXELON 6 mg”.
English: Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “EXELON 3 mg” on body.
Estonian: Peaaegu valget kuni helekollast värvi pulber oranži üla- ja oranži alaosaga kapslis.
English: - Exelon 6.0 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “EXELON 6 mg” on the body.
Estonian: - Exelon 6,0 mg kõvakapslid sisaldavad kollakasvalget kuni helekollast värvi pulbrit.
English: - Exelon 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “EXELON 4,5 mg” on the body.
Estonian: Exelon 4,5 mg kõvakapslid sisaldavad kollakasvalget kuni helekollast värvi pulbrit.
English: - Exelon 3.0 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “EXELON 3 mg” on the body.
Estonian: - Exelon 3,0 mg kõvakapslid sisaldavad kollakasvalget kuni helekollast värvi pulbrit.
English: Exelon 3.0 mg hard capsules
Estonian: Exelon 3,0 mg kõvakapslid
English: Exelon 15 cm N = 265
Estonian: Exelon 15 cm
English: 60 transdermal patches (sachet: paper/PET/alu/PAN) 90 transdermal patches (sachet: paper/PET/alu/PAN) 60 transdermal patches (sachet: paper/PET/PE/alu/PA)
Estonian: EU/1/98/066/027 7 transdermaalset plaastrit (kotike: paber/PET/alu/PAN) EU/1/98/066/028 30 transdermaalset plaastrit (kotike: paber/PET/alu/PAN) EU/1/98/066/043 7 transdermaalset plaastrit (kotike: paber/PET/PE/alu/PA) EU/1/98/066/044 30 transdermaalset plaastrit (kotike: paber/PET/PE/alu/PA)
English: You should not breast-feed during treatment with Exelon transdermal patches.
Estonian: Ravi ajal Exelon transdermaalsete plaastritega ei tohi last rinnaga toita.
English: Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “EXELON 4,5 mg” on body.
Estonian: Kapsli alaosale on valgelt trükitud “EXELON 4,5 mg”.
English: • Store in an upright position.
Estonian: • Hoida püstises asendis.
English: Gastrointestinal disorders
Estonian: Transdermaalne plaaster
English: (picture 8).
Estonian: (joonis 8).
English: Monitoring is required.
Estonian: Vajalik on järelevalve.
English: Use a new vial.
Estonian: Kasutage uut viaali.
English: OCT-1 study
Estonian: Uuring OCT-1
English: minutes before going to bed.
Estonian: 30 minutit enne magamaminekut.
English: Each box contains:
Estonian: Igas karbis on:
English: The majority of these adverse reactions are transient and most are mild or moderate.
Estonian: Enamik neist kõrvaltoimetest on mööduvad ning suurem osa on kerged või mõõdukad.
English: Cystadrops must be used every day for the medicine to work properly.
Estonian: Cystadropsi tuleb kasutada iga päev, et ravim korralikult toimiks.
English: 19 patients were under 6 years old, 21 between 6 and 12 years old and 29 between 12 and 18 years old.
Estonian: 19 patsienti olid alla 6 aasta vanad, 21 patsienti vahemikus 6 kuni 12 aastat vanad ning 29 patsienti vanuses 12 kuni 18 aastat vanad.
English: The treatment should not be stopped.
Estonian: Ravi ei tohi katkestada.
English: Therefore, oral cysteamine should not be used during pregnancy, particularly during the first trimester, unless clearly necessary.
Estonian: Seetõttu ei tohi suukaudset tsüsteamiini kasutada raseduse ajal, eriti esimesel trimestril, välja arvatud selge vajaduse korral.
English: • Repeat the step 3 for the other eye.
Estonian: • Korrake 3. sammu teise silmaga.
English: Wait for your next scheduled application and then continue with your regular routine.
Estonian: Oodake järgmise plaanilise manustamiskorrani ning jätkake siis tavapärase režiimiga.
English: None of the patients discontinued treatment over the 5 year follow-up.
Estonian: Ükski patsient ei katkestanud ravi 5-aastase jälgimisperioodi jooksul.
English: Before first opening: store in a refrigerator.
Estonian: Enne esmast avamist: hoida külmkapis.
English: After first opening: 7 days.
Estonian: Pärast esmast avamist: 7 päeva.
English: Do not put in any more drops until it is time for your next regular dose.
Estonian: Ärge pange silma rohkem tilku, enne kui on aeg järgmiseks tavapäraseks annuseks.
English: The efficacy and safety results are similar in both paediatric and adult populations.
Estonian: Efektiivsuse ja ohutuse tulemused on nii laste kui ka täiskasvanute populatsioonides sarnased.
English: Temporary (in average less than 1 minute) blurred vision or other visual disturbances may affect the ability to drive or use machines.
Estonian: Ajutine (keskmiselt alla 1 minuti) nägemise hägustumine või muud nägemishäired võivad mõjutada autojuhtimise ja masinate käsitsemise võimet.
English: If you wear soft contact lenses
Estonian: Kui te kannate pehmeid kontaktläätsi
English: CHOC study
Estonian: Uuring CHOC
English: This study assessed the safety and efficacy of Cystadrops during 5 years.
Estonian: Selles uuringus hinnati Cystadropsi ohutust ja efektiivsust 5 aasta vältel.
English: The mean IVCM total score was calculated for 11 patients.
Estonian: IVCM-i keskmine koondskoor arvutati 11 patsiendile.
English: Photophobia tended to improve over time.
Estonian: Fotofoobia kaldus aja jooksul vähenema.
English: Clinical data on safety and efficacy were collected during the 2 clinical trials (OCT-1 and CHOC studies).
Estonian: Ohutuse ja efektiivsuse kliinilisi andmeid koguti 2 kliinilises uuringus (OCT-1 ja CHOC).
English: Date of first authorisation: 19 January 2017 10.
Estonian: Müügiloa esmase väljastamise kuupäev: 19/01/2017
English: Those instructions are also available as an animated movie on www.cystadrops.net ‘QR code to be included'
Estonian: Juhised on saadaval ka animeeritud filmina veebisaidil www.cystadrops.net 'lisatakse QR-kood'
English: Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data).
Estonian: Esinemissagedusi määratletakse järgmiselt: väga sage (≥1/10); sage (≥1/100 kuni <1/10); aeg-ajalt (≥1/1000 kuni <1/100); harv (≥1/10 000 kuni <1/1000); väga harv (<1/10 000), teadmata (ei saa hinnata olemasolevate andmete alusel).
English: Do not stop using Cystadrops without speaking to your doctor.
Estonian: Ärge lõpetage Cystadropsi kasutamist ilma arstiga nõu pidamata.
English: • You must throw away the dropper bottle 7 days after you first opened it even if it is not empty.
Estonian: • Tilgapudel tuleb ära visata 7 päeva pärast esmast avamist, isegi kui pudel ei ole tühi.
English: If a drop misses your eye Try again.
Estonian: Kui tilk läheb silmast mööda Proovige uuesti.
English: Therefore talk to your doctor before stopping this treatment.
Estonian: Seetõttu pidage enne ravi lõpetamist nõu oma arstiga.
English: Do not use Cystadrops If you are allergic to cysteamine or any of the other ingredients of this medicine (listed in section 6).
Estonian: Ärge kasutage Cystadropsi: - kui olete tsüsteamiini või selle ravimi mis tahes koostisosa(de) (loetletud lõigus 6) suhtes allergiline.
English: Each carton box contains 1 vial and 1 dropper applicator.
Estonian: Üks pappkarp sisaldab 1 viaali ja 1 tilgaaplikaatorit.
English: • Do not refrigerate.
Estonian: • Mitte lasta külmuda.
English: Reported adverse reactions are listed below, by system organ class and by frequency (by patient).
Estonian: Täheldatud kõrvaltoimed on allpool loetletud organsüsteemi klasside ja esinemissageduse (patsiendipõhine) järgi.
English: • Get the dropper bottle and a mirror.
Estonian: • Võtke tilgapudel ja peegel.
English: Very common side effects (may affect more than 1 in 10 people)
Estonian: Väga sagedased kõrvaltoimed (võivad esineda enam kui 1 inimesel 10-st)
English: • Hold the dropper bottle, pointing down, between your thumb and fingers.
Estonian: • Hoidke tilgapudelit, ots allapoole, pöidla ja sõrmede vahel.
English: Pull down your eyelid with a clean finger, until there is a “pocket” between the eyelid and your eye.
Estonian: Tõmmake alalaug puhta sõrmega alla, kuni lau ja silma vahele tekib „tasku“.
English: Frequency, type and severity of adverse reactions in children are the same as in adults.
Estonian: Kõrvaltoimete sagedus, tüüp ja raskusaste lastel on samasugune nagu täiskasvanutel.
English: The recommended interval between each instillation is 4 hours.
Estonian: Soovitatav intervall manustamiste vahel on 4 tundi.
English: It could infect the drops.
Estonian: See võib tilga saastada.
English: • To avoid potential irritation, remove excess medicine around the eye with a moist tissue
Estonian: • Võimaliku ärrituse ärahoidmiseks kõrvaldage liigne ravim silma ümbrusest niiske lapiga
English: Belgique/België/Belgien
Estonian: Belgique/België/Belgien Recordati
English: • 1 dropper applicator.
Estonian: • 1 tilgaaplikaator.
English: It will facilitate the use of the drops.
Estonian: See lihtsustab tilkadekasutamist.
English: Cystadrops may have a minor influence on the ability to drive and use machines.
Estonian: Cystadrops võib mõjutada kergelt autojuhtimise ja masinate käsitsemise võimet.
English: Take special care not to touch the tip of the dropper with your fingers.
Estonian: Olge eriti ettevaatlik, et tilguti otsik ei puutuks kokku teie sõrmedega.
English: However, due to the results of animal studies in breast-feeding mothers and neonates (see section 5.3), women taking oral cysteamine should not breast-feed.
Estonian: Siiski tulenevalt loomkatsetes imetavate emasloomade ja vastsündinute kohta saadud andmetest (vt lõik 5.3), ei tohi suukaudset tsüsteamiini võtvad naised imetada.
English: Experimental administration of the drug causes depletion of somatostatin in several animal species.
Estonian: Ravimi eksperimentaalne manustamine põhjustab somatostatiini taseme alanemist mitmetel loomaliikidel.
English: Eye ointments should be administered last.
Estonian: Silmasalve tuleb manustada viimasena.
English: Cystadrops may be used in paediatric patients from 2 years of age at the same dose as in adults (see section 5.1).
Estonian: Cystadropsi võib kasutada lastel alates 2. eluaastast samas koguses nagu täiskasvanutel (vt lõik 5.1).
English: • After using Cystadrops, press a finger into the corner of your eye by the nose (picture 7), then gently massage your upper eyelid to spread the eye drops over the eye.
Estonian: • Pärast Cystadropsi kasutamist vajutage sõrmega silmanurka nina lähedal (joonis 7), seejärel masseerige õrnalt ülemist silmalaugu, et silmatilku üle silma levitada.
English: Contact with soft contact lenses should be avoided.
Estonian: Vältida kontakti pehmete kontaktläätsedega.
English: Studies in animals have shown a reduction on fertility (see section 5.3).
Estonian: Loomkatsed on näidanud fertiilsuse vähenemist (vt lõik 5.3).
English: The drop will go in here (picture 6).
Estonian: Tilk tuleb panna sinna (joonis 6).
English: Other medicines and Cystadrops Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Estonian: Teatage oma arstile või apteekrile, kui te kasutate või olete hiljuti kasutanud või kavatsete kasutada mis tahes muid ravimeid.
English: If blurred vision occurs at instillation, the patient must wait until the vision clears before driving or using machines.
Estonian: Kui manustamisel esineb nägemise hägustumist, peab patsient ootama, kuni nägemine selgineb, enne kui asub autot juhtima või masinaid käsitsema.
English: remove remove remove metal seal vial green protective cap grey stopper
Estonian: eemalda eemalda eemalda metallsulgur viaal roheline kaitsekate hall punnkork
English: Step 1: Before using a vial for the first time
Estonian: 1. samm: Enne viaali esmakordset kasutamist
English: • To avoid sticky eyes in the morning, it is recommended to apply the last drop of the day at least 30
Estonian: • Silmade hommikuse kleepumise vältimiseks on soovitatav manustada päeva viimane tilk vähemalt
English: • Tilt your head back.
Estonian: • Kallutage pea kuklasse.
English: In total 15 paediatric patients were exposed to Cystadrops whereof 3 subjects (including one 2 year and one 3 year old subject) being less than 6 years of age.
Estonian: Cystadropsiga puutus kokku 15 last, kellest 3 uuritavat (sh üks 2-aastane ja üks 3-aastane) olid alla 6 aasta vanad.
English: • Make sure that you do not lose the small white cap (picture 5) that comes on the top of the dropper.
Estonian: • Olge tähelepanelik ja ärge kaotage väikest valget korki (joonis 5), mis käib tilguti otsa.
English: You can usually carry on taking the drops, unless the effects are serious.
Estonian: Tavaliselt võite tilkade kasutamist jätkata, kui kõrvaltoimed ei ole rasked.
English: No carcinogenic studies have been conducted with cysteamine.
Estonian: Tsüsteamiiniga ei ole läbi viidud kantserogeensuse uuringuid.
English: At this dose, weight gain and survival of the offspring during lactation was also reduced.
Estonian: Selle annuse korral vähenes ka kaalus juurdevõtmine ning järglaste elulemus imetamise perioodil.
English: To avoid sticky eyes in the morning, the patient should be advised to apply the last drop of the day at least 30 minutes before going to bed.
Estonian: Silmade hommikuse kleepumise vältimiseks tuleb patsientidel soovitada manustada päeva viimane tilk vähemalt 30 minutit enne magamaminekut.
English: After 30 days of treatment and at a median frequency of 4 instillations per day, an average 30% decrease in the IVCM total score was observed.
Estonian: Pärast 30-päevast raviperioodi, mille vältel toimus mediaanselt 4 manustamist ööpäevas, täheldati keskmiselt 30% langust IVCM-i koondskooris.
English: • Keep Cystadrops at room temperature (it will facilitate the use of the dropper).
Estonian: • Hoidke Cystadropsi toatemperatuuril (see soodustab tilguti kasutamist).
English: Pharmacotherapeutic group: Ophtalmologicals, other ophtalmologicals, ATC code: S01XA21.
Estonian: Farmakoterapeutiline rühm: oftalmoloogias kasutatavad ained, teised oftalmoloogias kasutatavad ained, ATC-kood: S01XA21.
English: • Gently squeeze the dropper to release one drop of Cystadrops at a time.
Estonian: • Pigistage tilgutit õrnalt, et vabastada üks tilk Cystadropsi korraga.
English: Single doses of the drug inhibit prolactin secretion in animals.
Estonian: Ravimi ühekordsed annused inhibeerivad prolaktiini eritumist loomadel.